Potent, orally bioavailable diazabicyclic small-molecule mimetics of second mitochondria-derived activator of caspases.
暂无分享,去创建一个
Dajun Yang | Su Qiu | Han Yi | Jianfeng Lu | Chao-Yie Yang | Shaomeng Wang | Dajun Yang | Z. Nikolovska-Coleska | S. Qiu | S. Kang | Jianfeng Lu | Shaomeng Wang | Haiying Sun | Zaneta Nikolovska-Coleska | Haiying Sun | Yuefeng Peng | Qian Cai | Sanmao Kang | Yuefeng Peng | Han Yi | Q. Cai | Chao-Yie Yang | Sanmao Kang
[1] Xiaodong Wang,et al. A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death , 2004, Science.
[2] Robert L Moritz,et al. Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins , 2000, Cell.
[3] Yahong Lin,et al. A JNK-Dependent Pathway Is Required for TNFα-Induced Apoptosis , 2003, Cell.
[4] S. Fulda. Inhibitor of apoptosis proteins as targets for anticancer therapy , 2007, Expert review of anticancer therapy.
[5] G. Salvesen,et al. Apoptosis: IAP proteins: blocking the road to death's door , 2002, Nature Reviews Molecular Cell Biology.
[6] Stephen F. Betz,et al. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain , 2000, Nature.
[7] S. Srinivasula,et al. Mechanism of XIAP-mediated inhibition of caspase-9. , 2003, Molecular cell.
[8] Sheng Jiang,et al. Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP. , 2007, Journal of the American Chemical Society.
[9] Emad S. Alnemri,et al. correction: A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis , 2001, Nature.
[10] Geng Wu,et al. Structural basis of IAP recognition by Smac/DIABLO , 2000, Nature.
[11] Emad S. Alnemri,et al. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis , 2001, Nature.
[12] Shaomeng Wang,et al. Design and synthesis of a 1,5-diazabicyclo[6,3,0] dodecane amino acid derivative as a novel dipeptide reverse-turn mimetic , 2006 .
[13] Saul H Rosenberg,et al. Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer. , 2004, Journal of medicinal chemistry.
[14] Shaomeng Wang,et al. Design, synthesis, and evaluation of a potent, cell-permeable, conformationally constrained second mitochondria derived activator of caspase (Smac) mimetic. , 2006, Journal of medicinal chemistry.
[15] Shaomeng Wang,et al. Structure-based design of potent, conformationally constrained Smac mimetics. , 2004, Journal of the American Chemical Society.
[16] W. Fairbrother,et al. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs. , 2006, ACS chemical biology.
[17] J. Minna,et al. Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. , 2007, Cancer cell.
[18] Ingela Parmryd,et al. Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. , 2002, Journal of cell science.
[19] David L. Vaux,et al. IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis , 2007, Cell.
[20] Shaomeng Wang,et al. Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site. , 2004, Journal of medicinal chemistry.
[21] Vishva M. Dixit,et al. IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis , 2007, Cell.
[22] R. Korneluk,et al. XIAP: Apoptotic brake and promising therapeutic target , 2001, Apoptosis.
[23] J C Reed,et al. IAP family proteins--suppressors of apoptosis. , 1999, Genes & development.
[24] Xiaodong Wang,et al. Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition , 2000, Cell.
[25] Xueliang Fang,et al. Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization. , 2004, Analytical biochemistry.